Role of infliximab examined in treating Kawasaki disease
Monday, February 24, 2014 - 06:30
in Health & Medicine
A new study has looked at intensification of initial therapy for all children with Kawasaki Disease in order to prevent IVIG-resistance and associated coronary artery abnormalities by assessing the addition of the medication infliximab to current standard therapy. Kawasaki Disease is a severe childhood disease that many parents, even some doctors, mistake for an inconsequential viral infection. If not diagnosed or treated in time, it can lead to irreversible heart damage.